USPTO serial 98152034
NMDP BIOTHERAPIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 10, 2026
- Examiner
- BURCH, JILLIAN RENEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NMDP BIOTHERAPIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Minneapolis, MN, US
Minneapolis, MN, US
Minneapolis, MN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kourtney A. Mulcahy
Kourtney A. Mulcahy AKERMAN LLP777 SOUTH FLAGLER DRIVESUITE 1100 WEST TOWERWEST PALM BEACH, FL 33401Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for scientific research use, namely, for developing new cellular therapies and other treatments | ACTIVE | — |
| 005 | Biological tissue, namely, bone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for medical purposes | ACTIVE | — |
| 035 | Logistics management in the medical field, namely, management and coordination of medical services related to bone marrow and stem cell donation; Transportation logistics services, namely, arranging for the transportation of goods for others, particularly of products and samples from a collection site to entities who are developing new cellular therapies and other treatments related to bone marrow and peripheral blood stem cells | ACTIVE | — |
| 041 | educational and training services, namely, providing seminars, workshops, conferences, classes, lectures and presentations in the field of stem cells, stem cell research and stem cell applications and cellular therapies and distribution of course and educational materials in connection therewith | ACTIVE | — |
| 042 | providing medical research services for developing new cellular therapies and other treatments in the field of bone marrow and peripheral blood stem cells | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by National Marrow Donor Program
- Other trademarks owned by National Marrow Donor Program
- Other trademarks owned by National Marrow Donor Program
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named NMDP BIOTHERAPIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 10, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 10, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 19, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 19, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2026 | ALIE | ASSIGNED TO LIE | — |
| Feb 10, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Nov 7, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 11, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2025 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 28, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 26, 2025 | IUAF | USE AMENDMENT FILED | — |
| Mar 26, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 2, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 2, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 2, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 2, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 6, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 28, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 28, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 28, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 28, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 30, 2023 | NWAP | NEW APPLICATION ENTERED | — |